ScholarIQanswers from OpenAlex

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China

PaperCitations, authors & open-access status

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China have?

ScholarIQcitation count

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China has 64 citations in the OpenAlex counts ScholarIQ stores.

When was Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China published?

ScholarIQyear

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China has 2021 year in the ScholarIQ index.

What is the open-access status of Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China?

ScholarIQoa status

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China has green oa status in the ScholarIQ index.

What is the DOI of Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China?

ScholarIQdoi

The DOI for Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China is on the source record.

What is the PMID of Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China?

ScholarIQpmid

The PMID for Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China is on the source record.

What is the OpenAlex record for Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China?

ScholarIQopenalex

The OpenAlex for Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial